Christopher J Copeland (Christopher Copeland)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Liquid Chromatography Tandem Mass Spectrometry

Top Venues

Hepatology communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Prashanth Thevkar Nagesh, Yeonhee Cho, Yuan Zhuang, Mrigya Babuta, Marti Ortega-Ribera, Radhika Joshi, Veronika Lelakova, Arman Patel, Aditi Ashish Datta, Viliam Brezani, Yun-Cheng Hsieh, Adriana Ramos, Jeeval Mehta, Christopher J Copeland, Eleni Kanata, Zhenghui Gordon Jiang, Ioannis S Vlachos, John M Asara, null null, Gyongyi Szabo
In vivo Bruton's tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis. Science translational medicine 16 (759) (2024)
Mrigya Babuta, Caroline Morel, Marcelle Ribeiro, Aditi Ashish Datta, Charles Calenda, Christopher J Copeland, Imad A Nasser, Gyongyi Szabo
A novel experimental model of MetALD in male mice recapitulates key features of severe alcohol-associated hepatitis. Hepatology communications 8 (7) (2024)
Mrigya Babuta, Caroline Morel, Marcelle Ribeiro, Aditi Ashish Datta, Charles Calenda, Christopher J Copeland, Imad A Nasser, Gyongyi Szabo
A novel experimental model of MetALD in male mice recapitulates key features of severe alcohol-associated hepatitis. Hepatology communications 8 (7) (2024)
Mrigya Babuta, Caroline Morel, Marcelle Ribeiro, Aditi Ashish Datta, Charles Calenda, Christopher J Copeland, Imad A Nasser, Gyongyi Szabo
A novel experimental model of MetALD in male mice recapitulates key features of severe alcohol-associated hepatitis. Hepatology communications 8 (7) (2024)
Kim Bich Nguyen, Malte Roerden, Christopher J Copeland, Coralie M Backlund, Nory G Klop-Packel, Tanaka Remba, Byungji Kim, Nishant K Singh, Michael E Birnbaum, Darrell J Irvine, Stefani Spranger
Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression. eLife 12 (2023)